Paper324776
Regulation of the immune response. II. Repressor T cells in cyclophosphamide-induced tolerant mice.
Ramshaw IA and 2 others. Eur J Immunol, 1977. Cited by 69 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Download JSON
Cite this record
ConductScience Library. Regulation of the immune response. II. Repressor T cells in cyclophosphamide-induced tolerant mice. Papers, record 324776. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/324776
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Regulation of the immune response. II. Repressor T cells in cyclophosphamide-induced tolerant mice.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cyclophosphamide | Major topic |
| Immune Tolerance | Major topic |
| Immunity, Cellular | Major topic |
| T-Lymphocytes | Major topic |
| Animals | |
| Antilymphocyte Serum | |
| Female | |
| Hemolytic Plaque Technique | |
| Horses | |
| Hypersensitivity, Delayed | |
| Immunosuppression Therapy | |
| Lymphocytes | |
| Mice | |
| Mice, Inbred CBA |
Source PubMed
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31,231,378 | On Analyzing How the Th1/Th2 Phenotype of an Immune Response Is Determined: Classical Observations Must Not Be Ignored. | Front Immunol | 2019 | https://conductscience.org/library/papers/31231378 | PubMed |
| 24,684,592 | On the mechanism determining the TH1/TH2 phenotype of an immune response, and its pertinence to strategies for the prevention, and treatment, of certain infectious diseases. | Scand J Immunol | 2014 | https://conductscience.org/library/papers/24684592 | PubMed |
| 18,188,562 | Different immune correlates associated with tumor progression and regression: implications for prevention and treatment of cancer. | Cancer Immunol Immunother | 2008 | https://conductscience.org/library/papers/18188562 | PubMed |
| 15,819,695 | Increasing the foreignness of an antigen, by coupling a second and foreign antigen to it, increases the T helper type 2 component of the immune response to the first antigen. | Immunology | 2005 | https://conductscience.org/library/papers/15819695 | PubMed |
| 8,423,090 | Oral immunization of mice and swine with an attenuated Salmonella choleraesuis [delta cya-12 delta(crp-cdt)19] mutant containing a recombinant plasmid. | Infect Immun | 1993 | https://conductscience.org/library/papers/8423090 | PubMed |
| 6,976,414 | In vitro effects of 4-hydroperoxycyclophosphamide on human immunoregulatory T subset function. I. Selective effects on lymphocyte function in T-B cell collaboration. | J Exp Med | 1982 | https://conductscience.org/library/papers/6976414 | PubMed |
| 6,819,082 | The effects of cyclophosphamide on in vitro cytotoxic responses to a syngeneic tumour. | Cancer Immunol Immunother | 1982 | https://conductscience.org/library/papers/6819082 | PubMed |
| 3,849,980 | Chemoimmunotherapeutic effect of cyclophosphamide on the highly metastatic MAT 13762 tumor. | Cancer Immunol Immunother | 1985 | https://conductscience.org/library/papers/3849980 | PubMed |
| 3,724,838 | Experimental coccidioidomycosis: effects of cyclophosphamide in immunologic responses. | Mycopathologia | 1986 | https://conductscience.org/library/papers/3724838 | PubMed |
| 3,493,072 | A 6-thioguanine-resistant variant of the rat mammary adenocarcinoma 13762 that is more immunogenic. | Cancer Immunol Immunother | 1987 | https://conductscience.org/library/papers/3493072 | PubMed |
| 2,436,841 | Long-lasting enhancement of the delayed-type hypersensitivity response to heterologous erythrocytes in mice after a single injection of cyclophosphamide. | Clin Exp Immunol | 1986 | https://conductscience.org/library/papers/2436841 | PubMed |
| 1,828,396 | Inhibition of T suppressor cell function by local administration of an active cyclophosphamide derivative at the sensitization site. | Clin Exp Immunol | 1991 | https://conductscience.org/library/papers/1828396 | PubMed |
| 309,853 | Distinction between suppressors of the delayed-type hypersensitivity and the humoral response to sheep erythrocytes. | Immunology | 1978 | https://conductscience.org/library/papers/309853 | PubMed |
| 68,997 | Direct visualization of T lymphocytes bearing Ia antigens controlled by the I-J subregion. | J Exp Med | 1977 | https://conductscience.org/library/papers/68997 | PubMed |
| 33,118 | The capacity of microsomally-activated cyclophosphamide to induce immunosuppression in vitro. | Immunology | 1978 | https://conductscience.org/library/papers/33118 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/324776
GET https://conductscience.org/api/papers/v1/324776/authors